retatrutide guide How to Reconstitute Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

Volume = 1 mg / 5 mg/ml = 0.2 ml Challenge here: 0.2 ml is very difficult to measure with a standard syringe

Youre concerned about side effects and prefer starting with the medication that tends to have slightly milder GI issues

Network meta-analyses estimate approximately 23.77% average weight loss for retatrutide versus 16.79% for tirzepatide

Rare problems include bleeding, a leak from where the stomach or intestines were joined, a narrowing (scar tissue) that makes food harder to pass and blood clots

Tirzepatide (Personalized Tirzepatide+ / Zepbound / Mounjaro) Tirzepatide is a dual GIP and GLP-1 receptor agonist - meaning it activates two hormone pathways instead of one

Ressler has a special interest in treating patients with PCOS and increasing awareness of ovarian and breast cancer in the Jewish community through her advocacy work.